LGALS1 and metastatic malignant neoplasm in the lymph nodes: During the progression of CRC, galectin-1 is often significantly changed, meaning that overexpression of galectin-1 [24] correlates with poorly differentiated, invasive form of CRC with lymph node metastasis and shorter patient survival [25].